<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Di Benedetto G</submitter><funding>PRIN from the Italian Ministry of Research.</funding><pagination>11625</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9569968</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(19)</volume><pubmed_abstract>TRAIL, a member of TNF superfamily, is a potent inducer of neuronal death. Neurotoxic effects of TRAIL appear mediated by its death receptor TRAIL-R2/DR5. To assess the role of TRAIL/TRAIL-R2 pathway in AD-related neurodegeneration, we studied the impact of the treatment with amyloid-β (Aβ) upon cell viability and inflammation in TRAIL-R-deficient mice (TRAIL-R&lt;sup>-/-&lt;/sup>). Here, we demonstrate that the lack of TRAIL-R2 protects from death cultured TRAIL-R&lt;sup>-/-&lt;/sup> mouse embryonic hippocampal cells after treatment with either Aβ1-42 or TRAIL. Consistently, stereotaxic injection of Aβ1-42 resulted in blunted caspase activation, as well as in reduction of JNK phosphorylation and increased AKT phosphorylation in TRAIL-R&lt;sup>-/-&lt;/sup> mice. Moreover, the lack of TRAIL-R2 was associated</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β.</pubmed_title><pmcid>PMC9569968</pmcid><funding_grant_id>2017YH3SXK</funding_grant_id><pubmed_authors>Di Mauro R</pubmed_authors><pubmed_authors>Caltabiano R</pubmed_authors><pubmed_authors>Bellanca CM</pubmed_authors><pubmed_authors>Burgaletto C</pubmed_authors><pubmed_authors>Cantarella G</pubmed_authors><pubmed_authors>Bernardini R</pubmed_authors><pubmed_authors>Munafo A</pubmed_authors><pubmed_authors>Di Benedetto G</pubmed_authors><pubmed_authors>Serapide MF</pubmed_authors></additional><is_claimable>false</is_claimable><name>TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β.</name><description>TRAIL, a member of TNF superfamily, is a potent inducer of neuronal death. Neurotoxic effects of TRAIL appear mediated by its death receptor TRAIL-R2/DR5. To assess the role of TRAIL/TRAIL-R2 pathway in AD-related neurodegeneration, we studied the impact of the treatment with amyloid-β (Aβ) upon cell viability and inflammation in TRAIL-R-deficient mice (TRAIL-R&lt;sup>-/-&lt;/sup>). Here, we demonstrate that the lack of TRAIL-R2 protects from death cultured TRAIL-R&lt;sup>-/-&lt;/sup> mouse embryonic hippocampal cells after treatment with either Aβ1-42 or TRAIL. Consistently, stereotaxic injection of Aβ1-42 resulted in blunted caspase activation, as well as in reduction of JNK phosphorylation and increased AKT phosphorylation in TRAIL-R&lt;sup>-/-&lt;/sup> mice. Moreover, the lack of TRAIL-R2 was associated</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-18T19:32:48.981Z</modification><creation>2024-11-06T04:34:51.993Z</creation></dates><accession>S-EPMC9569968</accession><cross_references><pubmed>36232931</pubmed><doi>10.3390/ijms231911625</doi></cross_references></HashMap>